Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CASP6 | P55212 | 1/20 | 0.54 |
| ▸ | CCR1 | P32246 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | CCR5 | P51681 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CCR8 | P51685 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 2/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8571925 | 0.84 | ALDH1A1 (0.53) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL20671158 | 0.84 | CYP1A2 (0.46) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL31153402 | 0.84 | CYP1A2 (0.46) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL4541230 | 0.84 | CYP1A2 (0.46) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL19001483 | 0.84 | CYP1A2 (0.46) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL25233688 | 0.84 | CYP1A2 (0.46) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL25748417 | 0.84 | BACE1 (0.54) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL16750523 | 0.80 | CYP1A2 (0.44) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL30464282 | 0.80 | CYP1A2 (0.52) | CYP1A2LMNAKDM4EPOLBCASP6 | |
| SCHEMBL7991399 | 0.80 | CYP1A2 (0.43) | CYP1A2LMNAKDM4EPOLBCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312240-B2 | Reversible liquid organic system, method and process for loading and discharging hydrogen based on N-heterocycles | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-05-27 | — | — | US | disclosed |
| WO-2024123968-A1 | RNA TARGETING COMPOUNDS AND USES THEREOF | RANAR THERAPEUTICS, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| CN-113396126-B | N-heterocycle based reversible liquid organic systems, methods, and processes for loading and discharging hydrogen | 耶达研究与发展有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-11737351-B2 | Organic semiconductor material and organic photoelectric device using the same | Raynergy Tek Incorporation (TW) | 2023-08-22 | — | — | US | disclosed |
| US-11737351-B2 | Organic semiconductor material and organic photoelectric device using the same | Raynergy Tek Incorporation (TW) | 2023-08-22 | — | — | US | disclosed |
| WO-2023100844-A1 | COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT EMPLOYING SAME | 住友化学株式会社 | 2023-06-08 | — | — | WO | disclosed |
| WO-2023097007-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| US-11299581-B2 | Conjugated polymer and application thereof | RAYNERGY TEK INC. (TW) | 2022-04-12 | — | — | US | disclosed |
| US-20220024758-A1 | REVERSIBLE LIQUID ORGANIC SYSTEM, METHOD AND PROCESS FOR LOADING AND DISCHARGING HYDROGEN BASED ON N-HETEROCYCLES | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2022-01-27 | — | — | US | disclosed |
| EP-3318561-B1 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC (US) | 2021-12-22 | — | — | EP | disclosed |
| EP-2576540-A2 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | Sunovion Pharmaceuticals Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| CN-103038229-A | Heteroaryl compounds and methods of use thereof | SUNOVION PHARMACEUTICALS INC | 2013-04-10 | — | — | CN | disclosed |
| US-20120153274-A1 | AMBIPOLAR POLYMERIC SEMICONDUCTOR MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-06-21 | — | — | US | disclosed |
| US-20120153274-A1 | AMBIPOLAR POLYMERIC SEMICONDUCTOR MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-06-21 | — | — | US | disclosed |
| WO-2011150156-A2 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011150156-A2 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011025454-A1 | AMBIPOLAR POLYMERIC SEMICONDUCTOR MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-03-03 | — | — | WO | disclosed |
| US-7795802-B2 | Polymers for use in optical devices | CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) | 2010-09-14 | — | — | US | disclosed |
| US-20090111086-A1 | KIT FOR FACILE DEPOSITION AND EVALUATION OF SEMICONDUCTOR DEVICES | NATIONAL SCIENCE FOUNDATION | 2009-04-30 | — | — | US | disclosed |
| US-7365141-B2 | Solvent resistance; luminescent film-forming solvent processible polymer which contains cross-linking so as to increase its molar mass and to resist solvent dissolution, the cross-linking being such that the polymer retains semiconductive and luminescent properties; capable of charge transport | CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) | 2008-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737351-B2 | Organic semiconductor material and organic photoelectric device using the same | PPOX, GJA1, GJB2 | CYP1A2 262/4885LMNA 1500/4885KDM4E 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.